We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.25 | -6.31% | 48.25 | 47.20 | 49.50 | 51.00 | 47.60 | 51.00 | 498,635 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2023 16:21 | So we are in agreement that you are unaware of the current sales since the last update, even know you claimed they are atrocious. Basically scaremongering to aid your short position. | acer101 | |
05/1/2023 15:54 | So you are referring to an older statement which did not include sales for the last 3 months, cause how could it unless they contracted Mystic Meg. While their was a 60% reduction in covid sales up until the statements release it will be interesting to see what sales was like over the winter months, with the addition of monkeypox and strep A. | acer101 | |
05/1/2023 15:31 | Acer101Yes I know that for a fact as the company have stated in their guidance their revenues will reduce by at least 60% year on year. Have you not read the interims? | truant2tb1 | |
05/1/2023 15:04 | Fortunately for all ... "Despite being extremely infectious, experts insist the strain - which is a spin-off of Omicron - is just as mild as its ancestors" | london07 | |
05/1/2023 14:50 | Munchhopeyachickenbr | amanitaangelicus | |
05/1/2023 14:19 | tooMuch fLuff 5op cUmmings esp. ferU tom | andymunchkin | |
05/1/2023 10:51 | Seriously Andrew it's a binary event Ffs, win loose people are guessing, can't actually believe you boys got caught here again looooool Karma | tomzimerman | |
05/1/2023 10:37 | Trwunt2b the enthusiastic short seller giving out advice to others to sell!!!! Makes me feel sick reading your posts People should buy or sell based on their own research and certainly not from a post on advfn | tomzimerman | |
05/1/2023 10:07 | You know that for sure? As in you have seen the companies sales for the past few months? Sounds like your are just making a guess based on which ever side you fall on which in this case would be short. | acer101 | |
05/1/2023 09:53 | Anyone buying this needs their head looking at. You've got atrocious results coming around w/c 23rd Jan. that'll smash the SPBeer and popcorn time | truant2tb1 | |
05/1/2023 08:34 | Time to fill your boots and big knickers | datait | |
05/1/2023 08:24 | I feel we will end well blue today. dyor | srpactive | |
05/1/2023 06:30 | Is the Doc handing in his Sheriff's badge?Here, @DDS_DocHoliday expands on ideas, mindset and strategy for 2023 with @copytaster Companies and subjects covered by Doc include :#AVCT #BOO #BTCÂ #BEN #CHF #CGO #DEV #GGP #HVO #IDS #NCYT #POLB #RBD #VRShttps://total-ma | burtond1 | |
04/1/2023 16:27 | Keep looking this will rocket up and beyond soon enough just a little pull back first. | datait | |
04/1/2023 16:22 | looking for 80p top up | jackson83 | |
04/1/2023 16:15 | This happened before. Ups and downs and then whoosh. Nothing goes up in a straight line. But the global media is pushing for testing. Time will tell. | criticalthinker1 | |
04/1/2023 15:50 | I will say nothing of the sort. I have traded it, bought higher and lower from here. active | srpactive | |
04/1/2023 15:15 | I just feel the chart is being drawn for a rise later this week. dyor | srpactive | |
04/1/2023 13:33 | Front page earlier today - | tomboyb | |
04/1/2023 13:23 | Jackson is like advfn very own Jim Cramer, loooolHe went short at 80p so still has long way till he gets his dinner money back tbh | tomzimerman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions